{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nHorizontal dashed line is at IC50 (0.74 \u03bcM) as determined by the biofilm inhibition assay.\n(d and e) ZFH-2056 (Compound 50) dispersed biofilm as measured by confocal microscopy of UTI89 biofilms grown for 24 h, then incubated for an additional 16 h in the absence (d) or presence (e) of 0.3 \u03bcM ZFH-2056."}
{"final_json": [{"molecule_name": "ZFH-2056 (Compound 50)", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "IC50", "value": "0.74", "unit": "\u03bcM"}, {"molecule_name": "ZFH-2056", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": "0.3", "unit": "\u03bcM"}]}
{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* The median inhibitory concentration (IC50) of mannosides 1-3 and 6 on UTI89 biofilm formation.\n* The IC50 of 1-3 and 6 on UTI89 biofilm prevention.\n* Horizontal dashed line is at IC50 (0.74 \u03bcM) as determined by the biofilm inhibition assay.\n* 6 dispersed biofilm as measured by confocal microscopy of UTI89 biofilms grown for 24 h (D), then incubated for an additional 16 h in the presence of 0.3 \u03bcM 6 (E).\n* Cellular HAI titers (EC>90) are shown in parentheses. \n\nNote that some of these sentences may not have all the required components explicitly stated, but they provide enough context to identify specific molecules, proteins, or metrics."}
{"final_json": [{"molecule_name": "mannosides 1-3 and 6", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "IC50", "value": null, "unit": null}, {"molecule_name": "1-3 and 6", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "IC50", "value": null, "unit": null}, {"molecule_name": null, "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "IC50", "value": "0.74", "unit": "\u03bcM"}, {"molecule_name": "6", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": "0.3", "unit": "\u03bcM"}, {"molecule_name": null, "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "EC", "value": ">90", "unit": null}]}
{"raw_mentions": "Heptyl mannoside mimics the GlcNAc tail of oligomannose-3 and extends it further to increase interactions outside the binding pocket resulting in high affinity binding (Kd=5 nM).\nHeptyl mannose at 1 mM inhibited UPEC biofilm formation in vitro, suggesting that the mannose binding properties of the FimH adhesin is required for biofilm formation.\nThis resulted in a significant attenuation of virulence at 6 hours post-infection at 5 mM heptyl mannose (FIG. 5)."}
{"final_json": [{"molecule_name": "Heptyl mannoside", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "Kd", "value": "5", "unit": "nM"}, {"molecule_name": "Heptyl mannose", "protein_target_name": "FimH adhesin", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": "1", "unit": "mM"}, {"molecule_name": "heptyl mannose", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": "5", "unit": "mM"}]}
{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* Carboxylic acid 3j lost 10-fold potency relative to matched pair methyl ester 3j showing a 50% HA titer of only 60 \u03bcM.\n* Incorporation of an additional methyl ester in the 5-position of 3j, as with compound 4, resulted in a relatively large 3-fold enhancement in potency, with a 50% HA titer that can be inferred to be around 20 \u03bcM for compound 4, although the exact value is not explicitly stated for compound 4, the related compound 3j has a 50% HA titer of 60 \u03bcM.\n* Benzylic analogs 5a and 5b (pictured below) which have different conformational space and flexibility relative to direct phenyl substitution of the anomeric oxygen, as with to matched pairs 3a and 3b, show a 2-fold decrease (50% HA titer=60 \u03bcM) in potency."}
{"final_json": [{"molecule_name": "3j", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "50% HA titer", "value": "60", "unit": "\u03bcM"}, {"molecule_name": "4", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "50% HA titer", "value": "20", "unit": "\u03bcM"}, {"molecule_name": "3j", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "50% HA titer", "value": "60", "unit": "\u03bcM"}, {"molecule_name": "5a", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "50% HA titer", "value": "60", "unit": "\u03bcM"}, {"molecule_name": "5b", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "50% HA titer", "value": "60", "unit": "\u03bcM"}]}
{"raw_mentions": "Here are the extracted sentences:\n\nPerhaps the most unexpected finding from this study was that addition of another ester or amide substituted in the other meta position such as di-ester 15a and di-methyl amide 15b resulted in the two most potent mannoside inhibitors of FimH with activities of 150 nM and 370 nM, respectively.\nThe K<sub>D </sub>for FAM mannoside 20 was measured to be 0.17 \u03bcM while the 50% HA titer was only 125 \u03bcM.\nTwenty mannoside ligands with structural diversity and activities were evaluated in the HA titer cell assay ranging from 150 nM to 125 \u03bcM for their ability to competitively inhibit binding of FAM 20.\nInterestingly, it was found that all potently competed for FimH binding having EC<sub>50</sub>'s less than 0.25 \u03bcM but having no clear correlation of EC<sub>50 </sub>with the activity found in the HA cell assay (Table 13)."}
{"final_json": [{"molecule_name": "di-ester 15a", "protein_target_name": "FimH", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "IC50", "value": "150", "unit": "nM"}, {"molecule_name": "di-methyl amide 15b", "protein_target_name": "FimH", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "IC50", "value": "370", "unit": "nM"}, {"molecule_name": "FAM mannoside 20", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "Kd", "value": "0.17", "unit": "\u03bcM"}, {"molecule_name": "FAM mannoside 20", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "EC50", "value": "125", "unit": "\u03bcM"}, {"molecule_name": "mannoside ligands", "protein_target_name": "FimH", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "EC50", "value": "<0.25", "unit": "\u03bcM"}]}
{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* Mannoside derivatives that allow growth but inhibit biofilm formation at 50% or greater were verified by repeating the biofilm assay and performing titration curves to determine the IC50.\n* This fluorescent polarization assay provides a rapid method for monitoring improvements to receptor affinity during the synthetic process, as well as providing Kd binding affinity measurements."}
{"final_json": [{"molecule_name": "Mannoside derivatives", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "IC50", "value": null, "unit": null}, {"molecule_name": null, "protein_target_name": "receptor", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "Kd", "value": null, "unit": null}]}
{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* The most significant reduction in IBCs occurred with as little as 10 \u03bcM ZFH-2050 or ZFH-2056 (FIG. 20a).\n* Doses of 5 mg/kg and 10 mg/kg resulted in concentrations of nearly 5 mM in the urine 30 min after treatment (FIG. 20b).\n* Eight hours after dosing, ZFH-2056 remained at levels equal to or slightly below the IC50 (0.74 \u03bcM) as determined by biofilm inhibition."}
{"final_json": [{"molecule_name": "ZFH-2050", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": "10", "unit": "\u03bcM"}, {"molecule_name": "ZFH-2056", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": "10", "unit": "\u03bcM"}, {"molecule_name": null, "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": "5", "unit": "mg/kg"}, {"molecule_name": null, "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": "10", "unit": "mg/kg"}, {"molecule_name": null, "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": "5", "unit": "mM"}, {"molecule_name": "ZFH-2056", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "IC50", "value": "0.74", "unit": "\u03bcM"}]}
{"raw_mentions": "Here are the extracted sentences/rows that meet the criteria:\n\n\n3r1ZFH100\u20031N-[3-[3,4,5- trihydroxy-6- (hydroxymethyl) tetrahydropyran-2- yloxyphenyl] acetamide\tC<sub>14</sub>H<sub>19</sub>NO<sub>7</sub>\t313.3\t12.0\t0.216\u2002\t0.105\t314.3\t2.11 (s, 3H)  3.54-3.65 (m, 1H)  3.67-3.82 (m, 3H)  3.86-3.95 (m, 1H)  4.00 (dd, J = 3.30,  1.92 Hz, 1H) 5.47  (d, J = 1.37 Hz, 1H)  6.79-6.96 (m, 1H)  7.05-7.31 (m, 2H)  7.43 (t, J = 2.06 Hz,  1H)\n3s1ZFH75\u20032N-[4-[3,4,5- trihydroxy-6- (hydroxymethyl) tetrahydropyran-2- yl]oxyphenyl] acetamide\tC<sub>14</sub>H<sub>19</sub>NO<sub>7</sub>\t313.3\t8.0\t(~100)\t~59.4\t0.135\u2002\t0.108\t0.293\t14\u2009\u20022.10 (s, 3H)  3.53-3.65 (m, 1H)  3.67-3.82 (m, 3H)  3.83-3.94 (m, 1H)  3.99 (dd, J = 3.43,  1.79 Hz, 1H) 5.42  (d, J = 1.65 Hz, 1H)  6.98-7.18 (m, 2H)  7.36-7.57 (m, 2H)\n3q1ZFH95\u20033N-[2-[3,4,5- trihydroxy-6- (hydroxymethyl) tetrahydropyran-2- yl]oxyphenyl] acetamide\tC<sub>14</sub>H<sub>19</sub>NO<sub>7</sub>\t313.3\t12.5\t1.2\t335.9 [M + Na<sup>+</sup>]\t2.17 (s, 3H)  3.56-3"}
{"final_json": [{"molecule_name": "3r1ZFH100", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": null, "unit": null}, {"molecule_name": "3s1ZFH75", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": null, "unit": null}, {"molecule_name": "3q1ZFH95", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": null, "unit": null}]}
